Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures

OBJECTIVE: Study 311 (NCT02849626) was a global, multicenter, open‐label, single‐arm study that assessed safety, tolerability, pharmacokinetics, and pharmacokinetics/pharmacodynamics of once‐daily adjunctive perampanel oral suspension in pediatric patients (aged 4 to <12 years) with focal seizure...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogarasi, Andras, Flamini, Robert, Milh, Mathieu, Phillips, Steven, Yoshitomi, Shinsaku, Patten, Anna, Takase, Takao, Laurenza, Antonio, Ngo, Leock Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004020/
https://www.ncbi.nlm.nih.gov/pubmed/31912493
http://dx.doi.org/10.1111/epi.16413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004020/
https://www.ncbi.nlm.nih.gov/pubmed/31912493
http://dx.doi.org/10.1111/epi.16413

Ejemplares similares